CIK 0001651407
CKPT Checkpoint Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Jun 3, 2025.
Checkpoint Therapeutics, Inc. (CKPT) has 26 SEC Form 4 filings on file from 9 insiders, the latest filed on Jun 3, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
7 open-market trades have been scored at CKPT. The newest: Fortress Biotech, Inc. (10% owner) sold $129k of stock on May 29, 2025, filed Jun 3, 2025, scored 23 (weak). The largest of the 7 shown: James F Oliviero III (CEO, President and Director) sold $3.1M on Dec 18, 2024, scored 63 (notable). 2 insiders sold within 14 days of each other around Apr 1, 2025.
Last 90 days
Signals
Open-market buys and sells at Checkpoint Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Fortress Biotech, Inc. owner sell | $129k 100,000 shares | -2% | - | |
| 37Weak | William Garrett Gray Chief Financial Officer sell | $50k 12,322 shares | -1% | - | |
| 40Moderate | James F Oliviero III CEO, President and Director sell | $61k 15,090 shares | -0% | - | |
| 41Moderate | James F Oliviero III CEO, President and Director sell | $64k 19,564 shares | -1% | - | |
| 43Moderate | William Garrett Gray Chief Financial Officer sell | $272k 74,110 shares | -5% | - | |
| 60Notable | William Garrett Gray Chief Financial Officer sell | $1.1M 268,432 shares | -21% | - | |
| 63Notable | James F Oliviero III CEO, President and Director sell | $3.1M 822,397 shares | -20% | - |
Transactions
Every row filed, 40 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 29, 2025 | Fortress Biotech, Inc. owner | SOpen-market sale COMMON STOCK, PAR VALUE $0.0001 | -100,000 | $1.29 | $129k | 6,122,249 | Jun 3, 2025 |
| May 30, 2025 | Fortress Biotech, Inc. owner | DDisposition to issuer COMMON STOCK, PAR VALUE $0.0001 | -6,122,249 | $4.10 | $25M | 0 | Jun 3, 2025 |
| May 30, 2025 | Fortress Biotech, Inc. owner | DDisposition to issuer CLASS A COMMON STOCK, PAR VALUE $0.0001derivative | -700,000 | $0.00 | $0 | 0 | Jun 3, 2025 |
| May 30, 2025 | William Garrett Gray Chief Financial Officer | UTender of shares COMMON STOCK | -1,446,322 | - | - | 0 | May 30, 2025 |
| May 28, 2025 | Michael S Weiss director | AGrant or award COMMON STOCKindirect: See Note 2 | +12,195 | $0.00 | $0 | 137,007 | May 30, 2025 |
| May 30, 2025 | James F Oliviero III CEO, President and Director | UTender of shares COMMON STOCK | -3,759,929 | - | - | 0 | May 30, 2025 |
| May 28, 2025 | Barry M Salzman director | AGrant or award COMMON STOCK | +12,195 | $0.00 | $0 | 147,007 | May 30, 2025 |
| May 28, 2025 | Lindsay A Rosenwald Md director | AGrant or award COMMON STOCK | +12,195 | $0.00 | $0 | 157,007 | May 30, 2025 |
| May 28, 2025 | Neil Herskowitz director | AGrant or award COMMON STOCK | +12,195 | $0.00 | $0 | 147,007 | May 30, 2025 |
| May 28, 2025 | Christian Bechon director | AGrant or award COMMON STOCK | +12,195 | $0.00 | $0 | 141,718 | May 30, 2025 |
| May 28, 2025 | Sharma Amit director | AGrant or award COMMON STOCK | +12,195 | $0.00 | $0 | 94,246 | May 30, 2025 |
| May 29, 2025 | Lindsay A Rosenwald Md director | AGrant or award COMMON STOCK | +50,000 | $1.29 | $65k | 207,007 | May 30, 2025 |
| May 30, 2025 | Sharma Amit director | UTender of shares COMMON STOCK | -94,246 | - | - | 0 | May 30, 2025 |
| May 29, 2025 | Michael S Weiss director | AGrant or award COMMON STOCK | +50,000 | $1.29 | $65k | 187,007 | May 30, 2025 |
| May 30, 2025 | Barry M Salzman director | UTender of shares COMMON STOCK | -147,007 | - | - | 0 | May 30, 2025 |
| May 30, 2025 | Neil Herskowitz director | UTender of shares COMMON STOCK | -147,007 | - | - | 0 | May 30, 2025 |
| May 30, 2025 | Christian Bechon director | UTender of shares COMMON STOCK | -141,718 | - | - | 0 | May 30, 2025 |
| May 30, 2025 | Michael S Weiss director | UTender of shares COMMON STOCKindirect: See Note 2 | -187,007 | - | - | 0 | May 30, 2025 |
| May 30, 2025 | Lindsay A Rosenwald Md director | UTender of shares COMMON STOCK | -207,007 | - | - | 0 | May 30, 2025 |
| Apr 1, 2025 | William Garrett Gray Chief Financial Officer | SOpen-market sale COMMON STOCK | -12,322 | $4.05 | $50k | 1,446,322 | Apr 3, 2025 |
| Apr 2, 2025 | James F Oliviero III CEO, President and Director | SOpen-market sale COMMON STOCK | -15,090 | $4.04 | $61k | 3,759,929 | Apr 3, 2025 |
| Feb 26, 2025 | Fortress Biotech, Inc. owner | AGrant or award COMMON STOCK, PAR VALUE $0.0001 | +18,500 | $0.00 | $0 | 6,222,249 | Feb 27, 2025 |
| Feb 7, 2025 | James F Oliviero III CEO, President and Director | SOpen-market sale COMMON STOCK | -9,233 | $3.41 | $31k | 3,785,350 | Feb 11, 2025 |
| Feb 10, 2025 | James F Oliviero III CEO, President and Director | SOpen-market sale COMMON STOCK | -10,331 | $3.15 | $33k | 3,775,019 | Feb 11, 2025 |
| Feb 6, 2025 | William Garrett Gray Chief Financial Officer | SOpen-market sale COMMON STOCK | -74,110 | $3.67 | $272k | 1,458,644 | Feb 7, 2025 |
| Jan 30, 2025 | James F Oliviero III CEO, President and Director | AGrant or award COMMON STOCK (RESTRICTED) | +1,500,000 | $0.00 | $0 | 3,794,583 | Jan 31, 2025 |
| Jan 30, 2025 | William Garrett Gray Chief Financial Officer | AGrant or award COMMON STOCK (RESTRICTED) | +500,000 | $0.00 | $0 | 1,532,754 | Jan 31, 2025 |
| Dec 31, 2024 | Fortress Biotech, Inc. owner | AGrant or award COMMON STOCK, PAR VALUE $0.0001 | +81,407 | $0.00 | $0 | 3,816,941 | Jan 3, 2025 |
| Jan 1, 2025 | Fortress Biotech, Inc. owner | AGrant or award COMMON STOCK, PAR VALUE $0.0001 | +2,386,808 | $0.00 | $0 | 6,203,749 | Jan 3, 2025 |
| Dec 18, 2024 | James F Oliviero III CEO, President and Director | SOpen-market sale COMMON STOCK | -602,167 | $3.87 | $2.3M | 3,414,813 | Dec 20, 2024 |
| Dec 18, 2024 | William Garrett Gray Chief Financial Officer | SOpen-market sale COMMON STOCK | -268,432 | $4.01 | $1.1M | 1,032,754 | Dec 20, 2024 |
| Dec 19, 2024 | James F Oliviero III CEO, President and Director | SOpen-market sale COMMON STOCK | -220,230 | $3.38 | $744k | 3,194,583 | Dec 20, 2024 |
| Dec 20, 2024 | James F Oliviero III CEO, President and Director | GGift COMMON STOCK | -900,000 | $0.00 | $0 | 2,294,583 | Dec 20, 2024 |
| Dec 13, 2024 | Christian Bechon director | AGrant or award COMMON STOCK | +14,994 | $0.00 | $0 | 129,523 | Dec 17, 2024 |
| Dec 13, 2024 | Neil Herskowitz director | AGrant or award COMMON STOCK | +17,638 | $0.00 | $0 | 134,812 | Dec 17, 2024 |
| Dec 13, 2024 | William Garrett Gray Chief Financial Officer | AGrant or award Common Stock | +629,000 | $0.00 | $0 | 1,301,186 | Dec 17, 2024 |
| Dec 13, 2024 | James F Oliviero III CEO, President and Director | AGrant or award COMMON STOCK | +2,077,700 | $0.00 | $0 | 4,016,980 | Dec 17, 2024 |
| Dec 13, 2024 | Lindsay A Rosenwald Md director | AGrant or award COMMON STOCK | +12,638 | $0.00 | $0 | 144,812 | Dec 17, 2024 |
| Dec 13, 2024 | Barry M Salzman director | AGrant or award COMMON STOCK | +17,638 | $0.00 | $0 | 134,812 | Dec 17, 2024 |
| Dec 13, 2024 | Michael S Weiss director | AGrant or award COMMON STOCKindirect: See Note 3 | +12,638 | $0.00 | $0 | 124,812 | Dec 17, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Sharma Amitdirector
- Christian Bechondirector
- Fortress Biotech, Inc.owner
- William Garrett GrayChief Financial Officer
- Neil Herskowitzdirector
- James F Oliviero IIICEO, President and Director
- Lindsay A Rosenwald Mddirector, ceo, president, chair, officer, owner
- Barry M Salzmandirector
- Michael S Weissdirector, chair, officer, ceo
Questions about CKPT
Answered from the filings on this page, as of the latest one.
Are insiders buying CKPT?
No. In the last 90 days no insider at Checkpoint Therapeutics, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CKPT on the open market?
Fortress Biotech, Inc. (10% owner) sold $129k of CKPT on May 29, 2025 and filed the Form 4 on Jun 3, 2025. InsiderTell scored 23 (weak).
How many insiders file Form 4 at Checkpoint Therapeutics, Inc.?
9 people have filed a Form 4 at Checkpoint Therapeutics, Inc., among them Sharma Amit (director), Christian Bechon (director), Fortress Biotech, Inc. (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.